This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2009 Jan;16(1):66-9.

doi: 10.1177/107327480901600110.

Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene

Christina B Marquez¹, Erica E Smithberger, Sarah M Bair, Robert M Wenham, Neil A Fenske, L Frank Glass, Basil S Cherpelis

Affiliations

PMID: 19078932
DOI: 10.1177/107327480901600110

Free article

Case Reports

Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene

Christina B Marquez et al. Cancer Control. 2009 Jan.

Free article

. 2009 Jan;16(1):66-9.

doi: 10.1177/107327480901600110.

Authors

Christina B Marquez¹, Erica E Smithberger, Sarah M Bair, Robert M Wenham, Neil A Fenske, L Frank Glass, Basil S Cherpelis

Affiliation

¹ Department of Dermatology, University of South Florida, Tampa, FL 33612, USA.

PMID: 19078932
DOI: 10.1177/107327480901600110

No abstract available

PubMed Disclaimer

Similar articles

Keratoacanthomas associated with sorafenib therapy.
Kong HH, Cowen EW, Azad NS, Dahut W, Gutierrez M, Turner ML. Kong HH, et al. J Am Acad Dermatol. 2007 Jan;56(1):171-2. doi: 10.1016/j.jaad.2006.10.032. J Am Acad Dermatol. 2007. PMID: 17190642 Free PMC article. No abstract available.
[Sorafenib-induced multiple eruptive keratoacanthomas].
Jantzem H, Dupre-Goetghebeur D, Spindler P, Merrer J. Jantzem H, et al. Ann Dermatol Venereol. 2009 Dec;136(12):894-7. doi: 10.1016/j.annder.2009.09.010. Ann Dermatol Venereol. 2009. PMID: 20004316 French.
Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.
Arnault JP, Wechsler J, Escudier B, Spatz A, Tomasic G, Sibaud V, Aractingi S, Grange JD, Poirier-Colame V, Malka D, Soria JC, Mateus C, Robert C. Arnault JP, et al. J Clin Oncol. 2009 Aug 10;27(23):e59-61. doi: 10.1200/JCO.2009.23.4823. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597016 No abstract available.
[Oncology 2008].
Stemmler HJ, Heinemann V. Stemmler HJ, et al. Dtsch Med Wochenschr. 2008 Jun;133(25-26):1395-9. doi: 10.1055/s-2008-1081075. Epub 2008 Jun 3. Dtsch Med Wochenschr. 2008. PMID: 18521794 Review. German. No abstract available.
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
Miller K, Bergmann L, Albers P, Gschwend J, Jäger E, Keilholz U. Miller K, et al. Aktuelle Urol. 2010 May;41(3):193-6. doi: 10.1055/s-0030-1247395. Epub 2010 May 18. Aktuelle Urol. 2010. PMID: 20486036 German.

See all similar articles

Cited by

Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report.
Abbas MN, Tan WS, Kichenadasse G. Abbas MN, et al. J Med Case Rep. 2021 Sep 21;15(1):481. doi: 10.1186/s13256-021-03037-4. J Med Case Rep. 2021. PMID: 34544494 Free PMC article.
A solitary crateriform ulcer of the lower lip: a case report with review of literature.
Chauhan A, Chaudhary S, Agnihotri PG, Aadithya B. Chauhan A, et al. Indian J Dermatol. 2011 Jul;56(4):435-8. doi: 10.4103/0019-5154.84755. Indian J Dermatol. 2011. PMID: 21965859 Free PMC article.
[Cutaneous side effects of medical tumor therapy].
Degen A, Alter M, Schenck F, Kapp A, Gutzmer R. Degen A, et al. Hautarzt. 2011 Jun;62(6):444-50. doi: 10.1007/s00105-010-2042-4. Hautarzt. 2011. PMID: 21503784 German.
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer.
Schwandt A, von Gruenigen VE, Wenham RM, Frasure H, Eaton S, Fusco N, Fu P, Wright JJ, Dowlati A, Waggoner S. Schwandt A, et al. Invest New Drugs. 2014 Aug;32(4):729-38. doi: 10.1007/s10637-014-0078-5. Epub 2014 Mar 12. Invest New Drugs. 2014. PMID: 24619298 Clinical Trial.
Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study.
Chu EY, Wanat KA, Miller CJ, Amaravadi RK, Fecher LA, Brose MS, McGettigan S, Giles LR, Schuchter LM, Seykora JT, Rosenbach M. Chu EY, et al. J Am Acad Dermatol. 2012 Dec;67(6):1265-72. doi: 10.1016/j.jaad.2012.04.008. Epub 2012 May 18. J Am Acad Dermatol. 2012. PMID: 22609219 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information